88 related articles for article (PubMed ID: 10758576)
1. Angiogenesis and Cancer Control: From Concept to Therapeutic Trial.
Brem S
Cancer Control; 1999 Oct; 6(5):436-458. PubMed ID: 10758576
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice?
Mancuso A; Sternberg CN
Crit Rev Oncol Hematol; 2005 Jul; 55(1):67-81. PubMed ID: 15890525
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenesis therapy:concepts and importance of dosing schedules in clinical trials.
Mross K
Drug Resist Updat; 2000 Aug; 3(4):223-235. PubMed ID: 11498390
[TBL] [Abstract][Full Text] [Related]
4. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenesis: the fifth cancer treatment modality?
Camp-Sorrell D
Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
[TBL] [Abstract][Full Text] [Related]
6. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
Wachsberger P; Burd R; Dicker AP
Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Langer CJ; Natale RB
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
[TBL] [Abstract][Full Text] [Related]
8. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
[TBL] [Abstract][Full Text] [Related]
9. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches of angiogenesis inhibition: are we tackling the problem at the right level?
Griffioen AW
Trends Cardiovasc Med; 2007 Jul; 17(5):171-6. PubMed ID: 17574125
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis inhibitors in the treatment of lung cancer.
Sun S; Schiller JH
Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.
Yu Y; Wong J; Lovejoy DB; Kalinowski DS; Richardson DR
Clin Cancer Res; 2006 Dec; 12(23):6876-83. PubMed ID: 17145804
[TBL] [Abstract][Full Text] [Related]
14. Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope.
Deshpande HA; Gettinger SN; Sosa JA
Curr Opin Oncol; 2008 Jan; 20(1):19-24. PubMed ID: 18043252
[TBL] [Abstract][Full Text] [Related]
15. Vascular integrins in tumor angiogenesis: mediators and therapeutic targets.
Alghisi GC; Rüegg C
Endothelium; 2006; 13(2):113-35. PubMed ID: 16728329
[TBL] [Abstract][Full Text] [Related]
16. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
Plavetić ND; Letilović T; Vrbanec D
Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis inhibition in solid tumors.
Rosen LS
Cancer J; 2001; 7 Suppl 3():S120-8. PubMed ID: 11779082
[TBL] [Abstract][Full Text] [Related]
18. Clinical Trials of Antiangiogenesis Therapy on Gastric Cancer.
Wu LC; Zhang WD
Gastroenterology Res; 2008 Dec; 1(1):14-19. PubMed ID: 27994701
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic gene therapy of cancer: recent developments.
Tandle A; Blazer DG; Libutti SK
J Transl Med; 2004 Jun; 2(1):22. PubMed ID: 15219236
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis inhibition in prostate cancer: current uses and future promises.
Aragon-Ching JB; Madan RA; Dahut WL
J Oncol; 2010; 2010():361836. PubMed ID: 20169138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]